Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Marijuana Abuse

• Effects of Marijuana on Neuropathic Pain and Spasticity in Spinal Cord Injury Patients
• Study on Regulated Cannabis Sales in Pharmacies
• Longitudinal Outpatient Treatment for Cannabis Use Disorder
• Modulation of THC Effects by CBD: a Dose-ranging Study
• Cannabis Consumption and Driving Impairment Assessment on a Closed Course
• Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans
• SCORE Emerging Adult Cannabis Use & Stress
• Cannabis Use on Sedation for Oral Surgery Procedures
• Understanding Effects of Cannabis Use and Abstinence on Neural Glutamate Homeostasis
• The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
• Repeated Administration of Cannabis Varying in THC and CBD
• A Phase 1, AME Study of [4-14C]AEF0117 Following a Single Oral Dose in Healthy Male Subjects
• Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes
• Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
• Effect of PP-01 on Cannabis Withdrawal Syndrome
• Acute Effects of Cannabis on Everyday Life Memory
• Reinforcing Effects of Marijuana and Opioids
• SV2A Density Cannabis Use Disorder
• SV2A in Older Adults
• The Effect of Food on the Oral Bioavailability of AEF0117 in Healthy Volunteers
• Behavioral Pharmacology of THC and Beta-Myrcene
• Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
• A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder
• A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users
• Cannabis' Impact on Alcohol Consumption
• Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry
• Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial
• Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants
• Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD): SICA 2: SPECIFIC SIGNALING INHIBITOR IN CANNABIS ADDICTION
• A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users
• Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans
• Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC
• Detection of Cannabis Impairment With ISBRG's SpotLight-THC
• Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests
• A Randomized Controlled Trial of Guanfacine-er for Cannabis Use Disorder
• Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure
• Droperidol on Prevention of Cannabis Hyperemesis Syndrome
• Treatment With Cannabis Oil Containing CBD Only or 20:1 CBD:THC vs. Placebo of Persons With ADHD
• The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder
• Influence of Edible Marijuana on Endurance Exercise Performance
• Reducing the Harmful Effects of Cannabis Use: Finding the Optimal CBD:THC Ratio
• THC Memory & Reward Learning Pilot
• Standardized Field Test for Marijuana Impairment II
• Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
• The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A
• The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
• Cannabis Use, Cognition, and the Endocannabinoid System in HIV
• Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations
• THC + CBD and Memory Study
• Do Adolescents and Adults Differ in Their Acute Response to Cannabis?
• Pharmacokinetics and Pharmacological Effects of a Standardized Cannabis Preparation
• Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain
• Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement
• Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity
• Methodology for Developing an Occlusal Appliance With CBD Active Carrier
• The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products
• Reducing Cannabis Overuse With Prazosin
• Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
• Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise
• Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy
• N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use
• A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population
• Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans
• Varenicline for Co-occurring Cannabis and Tobacco Use
• Repeated Cannabis Administration on Experimental Pain and Abuse Liability
• Reward and Drug Effects on Mood and Brain Response
• Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers
• Cannabis Effects as a Function of Sex (CanSex)
• Effects of Pregnancy-associated Hormones on THC Metabolism in Women
• Efficacy of Inhaled Cannabis for Acute Migraine Treatment
• Age Differences in the Effects of Cannabis on Simulated Driving
• Cannabis Effects on Electroencephalography
• The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions
• Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment.
• Cannabis Impairment Detection Application (CIDA)
• Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products
• THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis
• Vivitrol Treatment for Cannabis Use Disorder
• Behavioral Pharmacology of Cannabis and Nicotine
• Cannabidiol for Treatment of Recent-onset Psychosis With Comorbid Cannabis Use
• Eye Tracking as a Biomarker of Cannabis Effects
• Safety and Efficacy of Inhaled Cannabis For the Uncontrolled Pain Relief in Patients With Advanced Cancer
• Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia
• Evaluation of an Eye Tracking Sensor to Detect Cannabis Impairment
• UH3 Varenicline for Cannabis Use Disorder
• Comparison of Safety, Tolerability and Pharmacokinetics of Medical Grade Cannabis (MGC) Orally Disintegrating Tablets With Buccal Sativex®, in Healthy Adult Volunteers
• Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa
• Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis
• Detection of Cannabis Impairment With an Eye Tracker
• Influence of Tobacco Use on Cannabis Use
• Impact of Progesterone on Stress Reactivity and Cannabis Use
• Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
• Opioid and Cannabinoid Interactions
• Marijuana Effects on Simulated Driving Performance
• Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
• Pharmacokinetic and Pharmacodynamic Effects of Smoked and Vaporized Cannabis
• Dose-response of Cannabis and Driving
• Lorcaserin for Cannabis Use Disorder
• Cannabis Oil for Chronic Non-Cancer Pain Treatment
• Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women
• Neural Correlates of Driving and Cannabis
• Tetrahydrocannabinol (THC) and Sleep
• Laboratory Smoking of Marijuana "Blunts"
• Cannabis Oil for Pain Effectiveness
• Behavioral Economic Analysis of Demand for Marijuana
• Substance Misuse To Psychiatric Disorders for Cannabis
• Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
• Progesterone for Cannabis Withdrawal
• Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam
• Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD)
• Gabapentin for Bipolar & Cannabis Use Disorders
• Effects of Marijuana on Symptoms of OCD
• Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
• Nabilone in Cannabis Users With PTSD
• Safety and Efficacy of Cannabis in Tourette Syndrome
• The Effect of Cannabis in Pancreatic Cancer
• Marijuana in Combination With Opioids in Palliative and Hospice Patients
• Effect of Medical Marijuana on Neurocognition and Escalation of Use
• N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms
• Brain Imaging of Cannabinoid Receptors
• Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations
• Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users
• Effects of Stress and Drug-cue Exposure (SCM)
• Differences in Cannabis Impairment and Its Measurement Due to Route of Administration
• Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder
• Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain
• The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients
• Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)
• N-Acetylcysteine for Youth Cannabis Use Disorder
• Marijuana's Impact on Alcohol Motivation and Consumption
• Vaping THC From Electronic Cigarettes
• Facilitating the Behavioral Treatment of Cannabis Use Disorder
• Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder
• Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients
• Enhancing Medication-based Analgesia in Humans
• Mobile Contingency Management for Marijuana and Tobacco Cessation
• Using a Field Performance Test on an iPad to Evaluate Driving Under the Influence of Cannabis
• Imaging the Neurochemistry of Drug Addiction With PET
• Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I
• Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder
• Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
• Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSD
• Neuroscience of Marijuana Impaired Driving
• The Pharmacokinetics, Safety, and Ease of Use of a Portable Metered-Dose Cannabis Inhaler
• Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III
• Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II
• Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I
• Hormones and Reduction in Co-users of Marijuana and Nicotine
• Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain
• Pregnenolone and Marijuana Dependence
• Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
• An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience.
• Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence
• Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics
• Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis
• Buspirone, Stress, and Attentional Bias to Marijuana Cues
• Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence
• Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study
• Study of the Relationship Between Dose-concentration-effect of Delta-9-tetrahydrocannabinol (THC) and the Ability to Drive in Chronic or Occasional Cannabis Users
• Cannabidiol: a Novel Intervention for Cannabis Use Problems?
• Baclofen Effects on Marijuana Dependence
• Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.
• Effectiveness of Cannabis in the Treatment of Tinnitus Patients
• Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
• Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
• The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes
• Effect of Oxytocin on Craving and Therapy Response
• Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation
• Fixed or Self-Titrated Dosages of Sativex on Cannabis Users
• Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence
• Quetiapine Pharmacotherapy for Cannabis Dependence
• The Role of Sleep in the Treatment of Cannabis Use Disorders
• Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment
• Clozapine for Cannabis Use in Schizophrenia
• Effects of Inhaled Cannabis on Driving Performance
• Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal
• Treatment for Cannabis Withdrawal and Dependence
• A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain
• Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia
• Cannabis Effects on Driving-related Skills of Young Drivers
• Vilazodone Treatment for Marijuana Dependence
• Vaporized Cannabis and Spinal Cord Injury Pain
• Behavioral Effects of Pregabalin and Cannabis
• Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in Israel
• Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence
• Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal
• Nicotine Patch for Marijuana Withdrawal
• Effects of Dronabinol (Oral THC) on Cannabis Use
• Nabilone for Cannabis Dependence: A Pilot Study
• Effect of Oxytocin on Stress in Marijuana Users
• Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine Dependence
• Medications Development for the Treatment of Cannabis Related Disorders
• Biobehavioral Effects of Topiramate on Cannabis-Related Outcomes in Adolescents
• Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked Cannabis
• Antagonist-Elicited Cannabis Withdrawal
• Cannabis for Inflammatory Bowel Disease
• Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation
• Nabilone & Marijuana Addiction
• Combined Pharmacotherapy for Cannabis Dependency
• A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana
• Gabapentin Treatment of Cannabis Dependence
• Galantamine Effects on Cognitive Function in Marijuana Users
• Study of Quetiapine Treatment for Cannabis Dependence
• Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
• Marijuana Drug Discrimination and Self-Administration
• The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep
• The Effect of Prescription Medications in Marijuana Users
• Buspirone Treatment for Marijuana Dependence
• Dronabinol Interactions With Cognitive Enhancing Drug in Humans
• Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy
• Effect of Quetiapine on Marijuana Withdrawal and Relapse
• Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana
• Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers
• Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
• Cannabis for Spasticity in Multiple Sclerosis
• Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults
• Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy
• First Episode Schizophrenia and Cannabis-Related Disorder Study
• An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
• Ph1 Marinol Interaction Study - Part 2 - 1
• Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal
• Ph1 Marinol Interaction Study - Part 1 - 1
• Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana
• Gabapentin Treatment of Cannabis Dependence
• Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
• Comparison Between Marijuana Smoked in Cigarette Paper Versus Cigar Paper
• Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse
• Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks
• Effect of Baclofen on Marijuana Withdrawal and Relapse
• Atomoxetine Treatment for ADHD and Marijuana Dependence
• A Placebo-Controlled Trial of Buspirone for Treatment of Marijuana Dependence
• The Effects of Marijuana on Orientation and Motor Coordination and Brain Metabolism in Regular Smokers of Marijuana
• Cannabis for Spasticity in Multiple Sclerosis
• Medicinal Cannabis for Painful HIV Neuropathy
• Effects of Smoked Marijuana on Neuropathic Pain
• Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals
• Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis
• Vaporization as a Smokeless Cannabis Delivery System
• Analgesic Efficacy of Smoked Cannabis
• Processing and Effects of Cannabis
• Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1
• Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2
• Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults
• Dronabinol Treatment for Marijuana Addiction
• Atomoxetine for the Treatment of Cannabis Dependence
• Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals
• Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence
• Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1
• Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder
• Effectiveness of Bupropion in Treating Marijuana Dependent Individuals
• Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1
• Lithium Cannabis Withdrawal Study
• Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS
• Substance Dependent Teens - Impact of Treating Depression Study 1 - 1